Table 5.
Comparison of demographic and clinical characteristics between the high risk and low risk groups
| Parameters | Patients in the high risk group (n = 21) | Patients in the low risk group (n = 35) | P value |
|---|---|---|---|
| Age, years (median, IQR) | 54.00 (48.00, 63.50) | 62.00 (54.00, 70.00) | 0.052 |
| Sex (Male) n (%) | 20 (95.2) | 30 (85.7) | 0.503 |
| BMI kg/m2 (median, IQR) | 22.05 (20.39, 23.35) | 23.94 (22.81, 25.10) | 0.002** |
| ECOG performance, n (%) (0) | 14 (66.7) | 26 (77.3) | 0.178 |
| HBV infection n (%) | 19 (90.5) | 25 (71.4) | 0.162 |
| HCV infection n (%) | 0 (0) | 5 (14.3) | 0.183 |
| Child-Pugh score n (%) (A) | 19 (90.1) | 35 (97.1) | 0.646 |
| AFP ng/mL (< 400) | 8 (38.1) | 23 (65.7) | 0.056 |
| BCLC stage n (%) (C) | 16 (76.2) | 21 (60.0) | 0.343 |
| Vascular invasion, n (%) (0) | 3 (14.3) | 15 (42.9) | 0.055 |
| Extrahepatic spread, n (%) | 7 (33.3) | 14 (40) | 0.777 |
| SAT volume index cm2/m2 (median, IQR) | 25.85 (18.74, 29.83) | 47.06 (40.20, 60.21) | 0.001 |
| SAT CT value HU (median, IQR) | -88.50 (-90.0, -80.01) | -100.6 (-103.4, -95.20) | 0.001 |
Abbreviations: BCLC: Barcelona Clinic Liver Cancer; BMI: body mass index; HBV: hepatitis B virus; HCV: hepatitis C virus; HU: Hounsfield unit; SAT: subcutaneous adipose tissue.
**
P < 0.01.